Published • loading... • Updated
Pharma Momentum Fuels Johnson & Johnson's Path to Double-Digit Upside
Summary by 247wallst.com
1 Articles
1 Articles
Pharma Momentum Fuels Johnson & Johnson's Path to Double-Digit Upside
The post Pharma Momentum Fuels Johnson & Johnson’s Path to Double-Digit Upside appeared first on 24/7 Wall St.. Our Johnson & Johnson (NYSE:JNJ) 24/7 Wall St. price target lands at $261.72, pointing to 11.28% upside from the current price of $235.18. Our recommendation is buy, and our model carries a 90% confidence level. JNJ has quietly become one of healthcare’s most reliable compounders again, with oncology firing and dividend support intact.…
·New York, United States
Read Full Article
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
